Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Vivos Therapeutics (VVOS) Times Interest Earned (2020 - 2023)

Historic Times Interest Earned for Vivos Therapeutics (VVOS) over the last 4 years, with Q4 2023 value amounting to -$2.3.

  • Vivos Therapeutics' Times Interest Earned fell 1361.26% to -$2.3 in Q4 2023 from the same period last year, while for Dec 2023 it was -$9.61, marking a year-over-year decrease of 1496.43%. This contributed to the annual value of -$9.61 for FY2023, which is 1516.39% down from last year.
  • Vivos Therapeutics' Times Interest Earned amounted to -$2.3 in Q4 2023, which was down 1361.26% from -$2.02 recorded in Q4 2022.
  • In the past 5 years, Vivos Therapeutics' Times Interest Earned registered a high of -$2.02 during Q4 2022, and its lowest value of -$4061.0 during Q2 2021.
  • For the 4-year period, Vivos Therapeutics' Times Interest Earned averaged around -$850.41, with its median value being -$174.71 (2022).
  • Per our database at Business Quant, Vivos Therapeutics' Times Interest Earned tumbled by 572238.5% in 2021 and then skyrocketed by 9989.09% in 2022.
  • Over the past 4 years, Vivos Therapeutics' Times Interest Earned (Quarter) stood at -$362.86 in 2020, then plummeted by 410.6% to -$1852.8 in 2021, then skyrocketed by 99.89% to -$2.02 in 2022, then dropped by 13.61% to -$2.3 in 2023.
  • Its last three reported values are -$2.3 in Q4 2023, -$2.02 for Q4 2022, and -$150.19 during Q3 2022.